GLIMEPIRIDA ACCORD 6mg tablets medication leaflet

A10BB12 glimepiride • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Glimepiride is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin and improving the sensitivity of cells to insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glimepiride is effective in preventing diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLIMEPIRIDA ACCORD 6mg

Substance: glimepiride

Date of last drug list: 01-08-2019

Commercial code: W65739004

Concentration: 6mg

Pharmaceutical form: tablets

Quantity: 180

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACCORD HEALTHCARE LIMITED - MAREA BRITANIE

Holder: ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA

Number: 11375/2019/04

Shelf life: 2 years

Concentrations available for glimepiride

1mg, 2mg, 3mg, 4mg, 6mg